Bee venom extracts
Brand names: Pharmalgen Bee Venom
Bee venom extracts are standardised allergen preparations used for allergen immunotherapy (desensitisation) in patients with confirmed systemic allergy to bee stings.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Repeated controlled administration of the venom allergen induces immune tolerance, shifting the allergic response and reducing the risk of severe systemic reactions on subsequent stings.
Prescribing in practice
- Administration carries a risk of anaphylaxis and must take place only in a specialist setting with full resuscitation facilities and trained staff immediately available.
- Confirm genuine venom allergy with appropriate diagnostic testing before starting, as immunotherapy is reserved for sensitised individuals with significant reactions.
- Concurrent beta-blocker or ACE inhibitor therapy may worsen or complicate the treatment of any anaphylactic reaction and should be reviewed.
Monitoring
Observe the patient for an appropriate period after each dose for systemic and local allergic reactions, with anaphylaxis management available throughout.
Counselling the patient
- This treatment gradually builds up your tolerance to bee stings.
- You will be observed after each dose because of the risk of an allergic reaction.
- Carry your prescribed adrenaline auto-injector and seek emergency help if you have a severe reaction.
Evidence & guidelines
Venom immunotherapy is established as effective for reducing the risk of severe systemic sting reactions in confirmed venom-allergic patients.
Reference: NICE TA246; BSACI; SmPC; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.